Registration Options

Activity Date: 04/20/2021

AAPP 2021 registration is closed.

Session Time and Location

The live session is complete.

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

There have been tremendous advances recently in the options available for treating bipolar disorder. In this compelling symposium, we will explore some of those advances and strategies for implementing them into clinical practice. The latest evidence-based diagnostic guidelines and treatments for bipolar depression will be deliberated and investigated. Novel agents and notable achievements in the treatment of disorders across the bipolar spectrum with potential applications from depression with mixed features to psychotic mania will also be discussed.

Faculty Information and Disclosures

Roger S. McIntyre, MD, FRCPC
Stephen M. Stahl, MD, PhD, DSc (Hon.)

View biographical information and disclosures

Learning Objectives

Topic
 

 

Continuing Education Credit and Disclosures

Activity Date: 04/20/2021
ACPE Contact Hours: 1.5
ACPE Number: 0284-9999-21-050-L01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.

Grant Support

This activity is supported by an educational grant from Sunovion.